'It took them 60+ years, but the World Health Organization seems to finally be buckling under the weight of evidence that shows the range of benefits to global health offered by cannabis products.
The organization appears to be ready to take a two-fold approach to rescheduling cannabis for both THC-based products as well as non-THC cannabidiol products. The WHO proposition appeared in a February 5, 2019 post:
The World Health Organization has proposed rescheduling cannabis within international law to take account of the growing evidence for medical applications of the drug, reversing its position held for the past 60 years that cannabis should not be used in legitimate medical practice.
The WHO Expert Committee on Drug Dependence met late last year to critically review available evidence on cannabis and related substances and to agree the most appropriate level of international control. (Source: BMJ)
The first major change would be to reduce the absurd Schedule IV categorization for the psychoactive component of marijuana, THC, which currently stands as the equivalent to heroin and a whole host of other truly addictive and dangerous substances. The second change is even more significant as the WHO has now made it clear that products in a non-THC form such as extracts should be removed completely from international drug controls.'
Read more: World Health Organization Admits Medical Benefits Of Cannabis — Moves To Change 1954 Policy